IDE-397

N/A

Report date: 2026/04/04 20:00:24
NME

Base Information

Drug NameIDE-397
Drug Alias NameIDE-397IDE397GSK-4362676
ClassificationSmall molecules
Mechanisms of ActionS-adenosylmethionine synthase isoform type-2 inhibitors
TargetsS-adenosylmethionine synthase isoform type-2
Therapy Area/IndicationsEsophageal adenocarcinomaSolid tumoursUrinary Bladder Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIdeaya Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcIdeaya Biosciences Inc
Inactive CompaniesN/A
Active IndicationsEsophageal adenocarcinomaSolid tumoursUrinary Bladder Neoplasms +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A